Metabolic Research Laboratory, University of Navarra, 31008 Pamplona, Spain.
Mediators Inflamm. 2010;2010:105489. doi: 10.1155/2010/105489. Epub 2010 Jun 1.
This study was designed to investigate whether leptin modifies angiotensin (Ang) II-induced proliferation of aortic vascular smooth muscle cells (VSMCs) from 10-week-old male Wistar and spontaneously hypertensive rats (SHR), and the possible role of nitric oxide (NO).
NO and NO synthase (NOS) activity were assessed by the Griess and (3)H-arginine/citrulline conversion assays, respectively. Inducible NOS (iNOS) and NADPH oxidase subutnit Nox2 expression was determined by Western-blot. The proliferative responses to Ang II were evaluated through enzymatic methods.
Leptin inhibited the Ang II-induced proliferative response of VSMCs from control rats. This inhibitory effect of leptin was abolished by NOS inhibitor, NMMA, and iNOS selective inhibitor, L-NIL, and was not observed in leptin receptor-deficient fa/fa rats. SHR showed increased serum leptin concentrations and lipid peroxidation. Despite a similar leptin-induced iNOS up-regulation, VSMCs from SHR showed an impaired NOS activity and NO production induced by leptin, and an increased basal Nox2 expression. The inhibitory effect of leptin on Ang II-induced VSMC proliferation was attenuated.
Leptin blocks the proliferative response to Ang II through NO-dependent mechanisms. The attenuation of this inhibitory effect of leptin in spontaneous hypertension appears to be due to a reduced NO bioavailability in VSMCs.
本研究旨在探讨瘦素是否能调节 10 周龄雄性 Wistar 大鼠和自发性高血压大鼠(SHR)主动脉血管平滑肌细胞(VSMCs)中血管紧张素(Ang)II 诱导的增殖,以及一氧化氮(NO)的可能作用。
通过格里西(Griess)和(3)H-精氨酸/瓜氨酸转化测定法分别评估 NO 和一氧化氮合酶(NOS)的活性。诱导型 NOS(iNOS)和 NADPH 氧化酶亚单位 Nox2 的表达通过 Western-blot 进行测定。通过酶促方法评估对 Ang II 的增殖反应。
瘦素抑制了来自对照大鼠的 VSMCs 对 Ang II 诱导的增殖反应。瘦素的这种抑制作用被 NOS 抑制剂 NMMA 和 iNOS 选择性抑制剂 L-NIL 所消除,而在瘦素受体缺陷型 fa/fa 大鼠中则未观察到。SHR 表现出血清瘦素浓度和脂质过氧化增加。尽管瘦素诱导的 iNOS 上调相似,但 SHR 的 VSMCs 显示出瘦素诱导的 NOS 活性和 NO 产生受损,以及基础 Nox2 表达增加。瘦素对 Ang II 诱导的 VSMC 增殖的抑制作用减弱。
瘦素通过 NO 依赖的机制阻断对 Ang II 的增殖反应。在自发性高血压中,这种瘦素抑制作用的减弱似乎是由于 VSMCs 中 NO 生物利用度降低所致。